Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [4]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN318796 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Interleukin 32 (IL32) (C-Term) antibody
- Antibody type
- Polyclonal
- Description
- Antisera to human IL-32 (CT) were raised by repeated immunisation of rabbits with highly purified antigen. Purified IgG was prepared by affinity chromatography.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Epitope
- C-Term
- Isotype
- IgG
- Vial size
- 0.1 mg
- Storage
- Store the antibody undiluted at 2-8°C for one month or (in aliquots) at -20°C for longer.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Modulation of autoimmunity by the latest interleukins (with special emphasis on IL-32).
The newest interleukins: recent additions to the ever-growing cytokine family.
Interleukin-32: a cytokine and inducer of TNFalpha.
Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.
Conti P, Youinou P, Theoharides TC
Autoimmunity reviews 2007 Jan;6(3):131-7
Autoimmunity reviews 2007 Jan;6(3):131-7
The newest interleukins: recent additions to the ever-growing cytokine family.
Chen Q, Carroll HP, Gadina M
Vitamins and hormones 2006;74:207-28
Vitamins and hormones 2006;74:207-28
Interleukin-32: a cytokine and inducer of TNFalpha.
Kim SH, Han SY, Azam T, Yoon DY, Dinarello CA
Immunity 2005 Jan;22(1):131-42
Immunity 2005 Jan;22(1):131-42
Interleukin-32, CCL2, PF4F1 and GFD10 are the only cytokine/chemokine genes differentially expressed by in vitro cultured rheumatoid and osteoarthritis fibroblast-like synoviocytes.
Cagnard N, Letourneur F, Essabbani A, Devauchelle V, Mistou S, Rapinat A, Decraene C, Fournier C, Chiocchia G
European cytokine network 2005 Dec;16(4):289-92
European cytokine network 2005 Dec;16(4):289-92
No comments: Submit comment
No validations: Submit validation data